Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
8.14
-0.06 (-0.73%)
At close: Aug 15, 2025, 3:59 PM
8.26
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT
Nanobiotix S.A. Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 49.74M | 66.33M | 75.28M | 21.63M | 41.39M | 63.02M | 83.92M | 102.34M |
Short-Term Investments | n/a | n/a | n/a | n/a | 2.81M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | 1K | n/a | 352K | 98K | 88K |
Other Long-Term Assets | 406K | 463K | 299K | -1K | 291K | 292K | 421K | 410K |
Receivables | 8.54M | 3.12M | 2.97M | 1.09M | 101K | 238K | 6.93M | n/a |
Inventory | n/a | n/a | 2.56M | 2.24M | 2.98M | 1.43M | -3.04M | 7.25M |
Other Current Assets | -1K | 8.73M | 6.53M | 8.67M | 7.89M | 8.18M | n/a | 6.29M |
Total Current Assets | 61.47M | 80.46M | 87.34M | 33.63M | 52.36M | 72.86M | 93.06M | 115.87M |
Property-Plant & Equipment | 5.54M | 5.75M | 6.25M | 6.48M | 7.12M | 7.41M | 8.19M | 7.54M |
Goodwill & Intangibles | 7K | 9K | 8K | 1K | 1K | 1K | 4K | 12K |
Total Long-Term Assets | 5.95M | 6.22M | 6.56M | 6.78M | 7.41M | 7.76M | 8.71M | 8.04M |
Total Assets | 67.42M | 86.68M | 93.9M | 40.41M | 59.77M | 80.62M | 101.77M | 123.92M |
Account Payables | 4.48M | 4.77M | 6.7M | 8.8M | 4M | 5.52M | 5M | 7.24M |
Deferred Revenue | 18.16M | n/a | 18.23M | 16.66M | 16.57M | 16.68M | 16.52M | 16.55M |
Short-Term Debt | 3.66M | 3.76M | 3.82M | 8.83M | 3.6M | 8M | 7.08M | 6.02M |
Other Current Liabilities | 8.27M | 26.56M | 19.86M | 17.65M | 17.75M | 18.45M | 17.34M | 17.69M |
Total Current Liabilities | 58.94M | 56.52M | 49.87M | 49.85M | 37.94M | 42.58M | 36.84M | 38.04M |
Long-Term Debt | 43.01M | 40.73M | 41.66M | 39.92M | 44.04M | 31.15M | 32.42M | 39.14M |
Other Long-Term Liabilities | 28.21M | 7.77M | 325K | 308K | 270K | 250K | 318K | 457K |
Total Long-Term Liabilities | 74.19M | 51.94M | 45.87M | 44.34M | 48.88M | 36.25M | 38.13M | 44.45M |
Total Liabilities | 133.12M | 108.46M | 95.74M | 94.19M | 86.81M | 78.83M | 74.98M | 82.48M |
Total Debt | 50.9M | 49.17M | 50.56M | 54M | 53.17M | 45.11M | 46.02M | 50.72M |
Common Stock | 1.42M | 1.42M | 1.41M | 1.06M | 1.05M | 1.05M | 1.04M | 1.04M |
Retained Earnings | -68.13M | -336.45M | -39.7M | -28.1M | -57.04M | -255.45M | -47M | -30.42M |
Comprehensive Income | -311.51M | 735K | -276.07M | -282.25M | -226.58M | 678K | -182.82M | -184.76M |
Shareholders Equity | -65.7M | -21.78M | -1.84M | -53.78M | -27.05M | 1.79M | 26.79M | 41.43M |
Total Investments | n/a | n/a | n/a | 1K | 2.81M | 352K | 98K | 88K |